Raphael Pharmaceutical (RAPH) Payables (2020 - 2025)
Raphael Pharmaceutical (RAPH) reported Payables of $1.1 million for Q4 2025, up 568.07% on a YoY basis from $166000.0 in Q4 2024, and up 46.89% sequentially from $755000.0 in Q3 2025.
Raphael Pharmaceutical (RAPH) Payables (2020 - 2025) Analysis & Trends
Raphael Pharmaceutical (RAPH) has 6 years of Payables data on file, last reported at $1.1 million in Q4 2025.
- For the quarter ending Q4 2025, Payables rose 568.07% year-over-year to $1.1 million; the trailing twelve-month figure through Dec 2025 stood at $1.1 million (up 568.07% YoY), and the FY2025 full-year result was $1.1 million, up 568.07% from the prior year.
- Payables climbed to $1.1 million in Q4 2025, from $755000.0 in the prior quarter.
- In the past five years, Payables ranged from a high of $1.1 million in Q4 2025 to a low of $12000.0 in Q3 2021.
- A 5-year average of $203571.4 and a median of $58000.0 in 2022 frame the typical range for Payables.
- Across the five-year window, Payables sank 72.43% in 2022 and jumped 568.07% in 2025, its largest moves.
- Tracing RAPH's Payables over 5 years: stood at $272000.0 in 2021, then slumped by 72.43% to $75000.0 in 2022, then soared by 42.67% to $107000.0 in 2023, then surged by 55.14% to $166000.0 in 2024, then jumped by 568.07% to $1.1 million in 2025.
- Business Quant data shows RAPH's Payables at $1.1 million in Q4 2025, $755000.0 in Q3 2025, and $41000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 731.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 8.82 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Raphael Pharmaceutical | 27.37 Mn | 27.33 Mn | - | 1.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.11 Mn |
| Sep 30, 2025 | 755,000.00 |
| Jun 30, 2025 | 41,000.00 |
| Mar 31, 2025 | 41,000.00 |
| Dec 31, 2024 | 166,000.00 |
| Sep 30, 2024 | 130,000.00 |
| Jun 30, 2024 | 26,000.00 |
| Mar 31, 2024 | 37,000.00 |
| Dec 31, 2023 | 107,000.00 |
| Sep 30, 2023 | 40,000.00 |
| Jun 30, 2023 | 39,000.00 |
| Dec 31, 2022 | 75,000.00 |
| Dec 31, 2021 | 272,000.00 |
| Sep 30, 2021 | 12,000.00 |
| Dec 31, 2020 | 366,000.00 |